Literature DB >> 17453146

Loss of heterozygosity studies in extracranial metastatic meningiomas.

Caroline Regna Gladin1, Ettore Salsano, Francesca Menghi, Marina Grisoli, Francesco Ghielmetti, Ida Milanesi, Bianca Pollo, Stefano Brock, Alberto Cusin, Ludovico Minati, Gaetano Finocchiaro, Maria Grazia Bruzzone.   

Abstract

Although most meningiomas are slow-growing tumours associated with favourable prognosis, they often present local recurrence after surgical treatment; by contrast, extracranial metastatic meningiomas are rare, occurring in less than 1% of the cases. Risk factors for distal spread remain largely unknown. We report three cases with lung or bone metastases from intracranial recurrent meningiomas. Loss of heterozygosity (LOH) analysis on 1p, 9p, 10q, 14q, and 22q was conducted in available primary, recurrent and metastatic lesions, showing the same LOH pattern in the distal metastases and in the intracranial meningioma. LOH at 1p, 14q and 9p, known to be associated with increased aggressiveness, were found. The results highlight the potential clinical relevance of integrating histopathological studies with molecular genetic analysis in the follow-up of patients with different types of meningiomas.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17453146     DOI: 10.1007/s11060-007-9386-3

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  21 in total

1.  Histopathologic indicators of recurrence in meningiomas: correlation with clinical and genetic parameters.

Authors:  Yoo-Jin Kim; Ralf Ketter; Wolfram Henn; Klaus D Zang; Wolf-Ingo Steudel; Wolfgang Feiden
Journal:  Virchows Arch       Date:  2006-10-03       Impact factor: 4.064

Review 2.  Extracranial metastatic meningioma.

Authors:  B E Figueroa; D J Quint; P E McKeever; W F Chandler
Journal:  Br J Radiol       Date:  1999-05       Impact factor: 3.039

3.  Chromosome 1p and 14q FISH analysis in clinicopathologic subsets of meningioma: diagnostic and prognostic implications.

Authors:  D X Cai; R Banerjee; B W Scheithauer; C M Lohse; B K Kleinschmidt-Demasters; A Perry
Journal:  J Neuropathol Exp Neurol       Date:  2001-06       Impact factor: 3.685

4.  Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas.

Authors:  J Boström; B Meyer-Puttlitz; M Wolter; B Blaschke; R G Weber; P Lichter; K Ichimura; V P Collins; G Reifenberger
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

5.  Loss of heterozygosity analysis of benign, atypical, and anaplastic meningiomas.

Authors:  John Y K Lee; Sydney Finkelstein; Ronald L Hamilton; Rapaka Rekha; Joseph T King; Bennett Omalu
Journal:  Neurosurgery       Date:  2004-11       Impact factor: 4.654

6.  A role for chromosome 9p21 deletions in the malignant progression of meningiomas and the prognosis of anaplastic meningiomas.

Authors:  Arie Perry; Ruma Banerjee; Christine M Lohse; Bette K Kleinschmidt-DeMasters; Bernd W Scheithauer
Journal:  Brain Pathol       Date:  2002-04       Impact factor: 6.508

Review 7.  The WHO classification of tumors of the nervous system.

Authors:  Paul Kleihues; David N Louis; Bernd W Scheithauer; Lucy B Rorke; Guido Reifenberger; Peter C Burger; Webster K Cavenee
Journal:  J Neuropathol Exp Neurol       Date:  2002-03       Impact factor: 3.685

8.  Metastasis in meningioma.

Authors:  S A Enam; S Abdulrauf; B Mehta; G M Malik; A Mahmood
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

9.  Meningiomas: analysis of loss of heterozygosity on chromosome 10 in tumor progression and the delineation of four regions of chromosomal deletion in common with other cancers.

Authors:  Dana Mihaila; Jorge A Gutiérrez; Mark L Rosenblum; Irene F Newsham; Oliver Bögler; Sandra A Rempel
Journal:  Clin Cancer Res       Date:  2003-10-01       Impact factor: 12.531

10.  Histologically benign metastatic meningioma: morphological and cytogenetic study. Case report.

Authors:  Miguel Cerdá-Nicolás; Concha Lopez-Gines; Miguel Perez-Bacete; Pedro Roldan; Fernando Talamantes; José Barberá
Journal:  J Neurosurg       Date:  2003-01       Impact factor: 5.115

View more
  6 in total

Review 1.  A review of malignant meningiomas: diagnosis, characteristics, and treatment.

Authors:  Simon Hanft; Peter Canoll; Jeffrey N Bruce
Journal:  J Neurooncol       Date:  2010-08-21       Impact factor: 4.130

2.  Genetic analysis of a malignant meningioma and associated metastases.

Authors:  Kristin Huntoon; Ayse Selen Yilmaz; Maciej Pietrzak; Xi Chen; Pearlly Yan; Amanda Ewart Toland; J Bradley Elder
Journal:  Acta Neurochir (Wien)       Date:  2022-01-03       Impact factor: 2.216

3.  Metastatic meningiomas: an unusual clinical and pathological diagnosis with highly variable outcome.

Authors:  Fabien Forest; Sid-Ali Berremila; Cezar Gyenes; Carole Ginguéné; Radwan Kassir; Abdulrazzaq Sulaiman; Basile Pasquier; Jack Porcheron; Michel Péoc'h
Journal:  J Neurooncol       Date:  2014-08-01       Impact factor: 4.130

4.  WHO Grade I Meningioma Metastasis to the Lung 26 Years after Initial Surgery: A Case Report and Literature Review.

Authors:  Toshiyuki Enomoto; Mikiko Aoki; Yuki Kouzaki; Hiroshi Abe; Naoko Imamura; Akinori Iwasaki; Tooru Inoue; Kazuki Nabeshima
Journal:  NMC Case Rep J       Date:  2019-09-12

5.  Solitary pulmonary metastasis after meningioma surgery of the head: a case report.

Authors:  Takahiro Utsumi; Tomohito Saito; Mitsuaki Ishida; Natsumi Maru; Hiroshi Matsui; Yohei Taniguchi; Haruaki Hino; Tomohiro Murakawa
Journal:  Surg Case Rep       Date:  2022-02-05

Review 6.  Multiple pulmonary metastases in recurrent intracranial meningioma: Case report and literature review.

Authors:  Ming Wang; Renya Zhan; Chong Zhang; Yongqing Zhou
Journal:  J Int Med Res       Date:  2016-03-04       Impact factor: 1.671

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.